Review article: hyperammonaemic and catabolic consequences of upper gastrointestinal bleeding in cirrhosis
Open Access
- 19 March 2009
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 29 (8) , 801-810
Abstract
Summary: Background Upper gastrointestinal (UGI) bleeding in patients with cirrhosis of the liver induces hyperammonaemia and leads to a catabolic cascade that precipitates life‐threatening complications. The haemoglobin molecule is unique because it lacks the essential amino acid isoleucine and contains high amounts of leucine and valine. UGI bleed therefore presents the gut with protein of very low biologic value, which may be the stimulus to induce net catabolism.Aim To describe the hyperammonaemic and catabolic consequences of UGI bleeding in cirrhosis.Methods A semi‐structured literature search was performed using PubMed and article references.Results It has recently been proven that (‘simulation of ’) a UGI bleed in patients with cirrhosis leads to impaired protein synthesis that can be restored by intravenous infusion of isoleucine. This may have therapeutic implications for the function of rapidly dividing cells and short half‐life proteins such as clotting factors. Renal and small bowel ammoniagenesis were shown to be the most prominent causes for the hyperammonaemia that resulted from a UGI bleed. This provides an explanation for the therapeutic failure of the current clinical therapies that are aimed at large bowel‐derived ammonia production. Isoleucine infusion did not diminish renal ammoniagenesis.Conclusions New pharmacological therapies to diminish postbleeding hyperammonaemia should target the altered inter‐organ ammonia metabolism and promote ammonia excretion and/or increase the excretion of precursors of ammoniagenesis, e.g. l‐ornithine–phenylacetate.Keywords
This publication has 49 references indexed in Scilit:
- Isoleucine infusion during “simulated” upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patientsHepatology, 2007
- l-Ornithine phenylacetate (OP): A novel treatment for hyperammonemia and hepatic encephalopathyMedical Hypotheses, 2007
- Upper gastrointestinal bleeding: an ammoniagenic and catabolic event due to the total absence of isoleucine in the haemoglobin moleculeMedical Hypotheses, 1999
- Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhageHepatology, 1998
- Hepatic encephalopathy and ascitesThe Lancet, 1997
- Ammonia and GABA-ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathyHepatology, 1997
- The regulation of neutral amino acid transport in mammalian cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983
- Differential effects of isoleucine deprivation on cell motility, membrane transport and DNA synthesis in NIL 8 hamster cellsExperimental Cell Research, 1975
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973
- Episodic Stupor Associated with an Eck Fistula in the Human with Particular Reference to the Metabolism of Ammoniaxs12Journal of Clinical Investigation, 1954